Concepedia

Author

Dagmar Oette

Duke Medical Center

Also Known As

D H Oette, D Oette, D. Oette, Dagmar H. Oette, Dagmar Oette

17

Publications

3.3K

Citations

11

H-Index

13

Concepts

All Affiliations

Duke Medical CenterSouthwestern Medical CenterDuke University HospitalThe University of Texas Southwestern Medical CenterLahey Hospital and Medical Center
DO

About

Dagmar Oette is an author at Duke Medical Center specializing in hiv, immunology, and primary immunodeficiency.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

627

2

Immunology

1

1

627

3

Hematology

1

1

627

4

Immune Cell Development

1

1

627

5

Immune Function

1

1

627

Dagmar Oette

×

11

Publications

3.3K

Citations

11

H-Index

YearCitations

Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow Transplantation

Stephen J. Brandt, W P Peters, Susan K. Atwater,

New England Journal of Medicine

1988

768

Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced Myelosuppression

Karen Antman, James D. Griffin, Anthony Elias,

New England Journal of Medicine

1988

684

Effect of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor on Myelopoiesis in the Acquired Immunodeficiency Syndrome

Jerome E. Groopman, Ronald T. Mitsuyasu, Michael DeLeo,

New England Journal of Medicine

1987

627

Recombinant Granulocyte-Macrophage Colony-Stimulating Factor after Autologous Bone Marrow Transplantation for Lymphoid Cancer

John Nemunaitis, Susan N. Rabinowe, Jack W. Singer,

New England Journal of Medicine

1991

495

A randomized placebo-controlled phase III study of granulocyte- macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)

JM Rowe, J. W. Andersen, Mazza Jj,

Blood

1995

446

Pentoxifylline Therapy in Human Immunodeficiency Virus--Seropositive Persons with Tuberculosis: A Randomized, Controlled Trial

Robert S. Wallis, Peter Nsubuga, Christopher Whalen,

The Journal of Infectious Diseases

1996

73

Dosing regimen of granulocyte-macrophage colony-stimulating factor to support dose-intensive chemotherapy.

James A. Neidhart, A Mangalik, Christine A. Stidley,

Journal of Clinical Oncology

1992

58

Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for relapsed non-Hodgkin's lymphoma: blood and bone marrow progenitor growth studies. A phase II Eastern Cooperative Oncology Group Trial

H M Lazarus, Janet Andersen, MG Chen,

Blood

1991

45

Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating-factor support for dose-intensive cyclophosphamide, etoposide, and cisplatin

Jonathan C. Yau, James A. Neldhart, Pierre L. Triozzi,

American Journal of Hematology

1996

35

Cyclophosphamide in combination with sargramostim for treatment of recurrent medulloblastoma

Albert Moghrabi, Herb Fuchs, Mark T. Brown,

Medical and Pediatric Oncology

1995

27

Page 1